April 25, 2019
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: | Infinity Pharmaceuticals, Inc. |
Registration Statement on FormS-3 (FileNo. 333-230258) |
Request for Acceleration |
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Infinity Pharmaceuticals, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on FormS-3 (FileNo. 333-230258), so that it may become effective at 4:00 p.m. Eastern time on April 29, 2019, or as soon thereafter as practicable or at such later time as the Registrant may orally request via telephone call to the staff.
Very truly yours,
INFINITY PHARMACEUTICALS, INC. | ||
By: | /s/ Seth A. Tasker | |
Name: Title: | Seth A. Tasker Vice President, General Counsel & Secretary |